Healthcare provider profile · identity verified

Peter R Paul, MD

Geriatric Medicine · ANN ARBOR, MI · NPI 1407853617

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1004	315
Lisinopril	Lisinopril	945	284
Amlodipine Besylate	Amlodipine Besylate	789	232
Losartan Potassium	Losartan Potassium	505	151
Metoprolol Succinate	Metoprolol Succinate	444	135
Levothyroxine Sodium	Levothyroxine Sodium	421	115
Omeprazole	Omeprazole	383	117
Furosemide	Furosemide	307	101
Rosuvastatin Calcium	Rosuvastatin Calcium	278	93
Metformin Hcl Er	Metformin Hcl	231	82
Simvastatin	Simvastatin	213	76
Tamsulosin Hcl	Tamsulosin Hcl	211	76
Metformin Hcl	Metformin Hcl	206	68
Atenolol	Atenolol	181	53
Jardiance	Empagliflozin	172	56
Eliquis	Apixaban	169	60
Metoprolol Tartrate	Metoprolol Tartrate	147	49
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	138	45
Gabapentin	Gabapentin	137	45
Allopurinol	Allopurinol	129	42
Hydrochlorothiazide	Hydrochlorothiazide	129	50
Albuterol Sulfate Hfa	Albuterol Sulfate	126	55
Pravastatin Sodium	Pravastatin Sodium	125	31
Potassium Chloride	Potassium Chloride	123	39
Duloxetine Hcl	Duloxetine Hcl	108	34
Glipizide	Glipizide	103	33
Carvedilol	Carvedilol	90	28
Bupropion Xl	Bupropion Hcl	86	20
Spironolactone	Spironolactone	86	28
Clopidogrel	Clopidogrel Bisulfate	84	29
Glipizide Er	Glipizide	79	22
Trazodone Hcl	Trazodone Hcl	75	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	72	22
Tizanidine Hcl	Tizanidine Hcl	69	32
Citalopram Hbr	Citalopram Hydrobromide	68	25
Ezetimibe	Ezetimibe	67	36
Fluticasone Propionate	Fluticasone Propionate	63	37
Tramadol Hcl	Tramadol Hcl	63	23
Prednisone	Prednisone	60	43
Xarelto	Rivaroxaban	60	20
Pantoprazole Sodium	Pantoprazole Sodium	57	25
Sertraline Hcl	Sertraline Hcl	57	17
Venlafaxine Hcl Er	Venlafaxine Hcl	57	11
Donepezil Hcl	Donepezil Hcl	56	16
Lovastatin	Lovastatin	56	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	54	16
Novolog Flexpen	Insulin Aspart	51	19
Escitalopram Oxalate	Escitalopram Oxalate	48	17
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	47	17
Finasteride	Finasteride	45	18
Ozempic	Semaglutide	45	12
Montelukast Sodium	Montelukast Sodium	44	16
Oxybutynin Chloride	Oxybutynin Chloride	43	17
Nitroglycerin	Nitroglycerin	41	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	12
Famotidine	Famotidine	38	16
Klor-Con M20	Potassium Chloride	38	12
Azithromycin	Azithromycin	37	24
Meloxicam	Meloxicam	36	15
Nabumetone	Nabumetone	36	suppressed
Colchicine	Colchicine	34	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	13
Tiotropium Bromide	Tiotropium Bromide	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	12
Paroxetine Hcl	Paroxetine Hcl	33	12
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	22
Alendronate Sodium	Alendronate Sodium	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	11
Humalog Kwikpen U-100	Insulin Lispro	27	13
Buspirone Hcl	Buspirone Hcl	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Mounjaro	Tirzepatide	25	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	14
Synthroid	Levothyroxine Sodium	23	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	22	suppressed
Dutasteride	Dutasteride	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	17
Alprazolam	Alprazolam	18	16
Meclizine Hcl	Meclizine Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Cephalexin	Cephalexin	17	14
Doxycycline Hyclate	Doxycycline Hyclate	17	11
Pregabalin	Pregabalin	17	suppressed
Amoxicillin	Amoxicillin	16	11
Clonidine Hcl	Clonidine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	11
Januvia	Sitagliptin Phosphate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error